Skip to main content

Ray Blind, Ph.D.

Assistant Professor, Departments of Medicine, Biochemistry and Pharmacology

The Blind Lab is focused on exploring the structure, function and signaling properties of nuclear inositide lipids and soluble inositol phosphates. Our group uses genomics, structural biology and chemical genetics to determine new mechanisms of nuclear signaling. We then use of that new signaling information to develop novel drug discovery platforms, with potential in several cancers (glioblastoma and hepatocellular carcinoma) and metabolic liver diseases (fatty liver, hepatosteatosis and type II diabetes).